This inventor holds 1 USPTO granted patent. Top assignees: Behringwerke Aktiengesellschaft, Dana-Farber-Cancer Institute Inc.. Active years: 1995.
Company Filing History:
1 out of 340 
1 out of 1,265 
Years Active: 1995
Title: The Innovative Contributions of Ingrid Muller-Fleckenstein
Introduction
Ingrid Muller-Fleckenstein is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of vectors for cell line establishment. Her work has implications for both research and therapeutic applications.
Latest Patents
Muller-Fleckenstein holds a patent for the H. saimiri-HTLV-X region vector. This innovative vector can be utilized to establish continuous cell lines of difficult-to-grow cells, such as human T-cells. Additionally, it can be employed to obtain specific cell products and in methods for screening new compounds. This patent highlights her expertise in genetic engineering and cell biology.
Career Highlights
Throughout her career, Muller-Fleckenstein has worked with prestigious organizations, including the Dana-Farber Cancer Institute and Behringwerke Aktiengesellschaft. Her experience in these institutions has allowed her to collaborate with leading scientists and contribute to groundbreaking research in cancer and immunology.
Collaborations
Muller-Fleckenstein has collaborated with esteemed colleagues such as Marie-Christine Dokhelar and William A. Haseltine. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Ingrid Muller-Fleckenstein's contributions to biotechnology and her innovative patent demonstrate her significant role in advancing scientific knowledge and applications. Her work continues to influence the field and inspire future research endeavors.